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Objectives. Prophylactic vena cava filters (VCF) are efficient in preventing pulmonary embolism. Filter retrieval avoids
the potential long-term complications of permanent VCF. Clinical evaluation was focused on filter-related complications
and feasibility of retrieval in high-risk trauma patients.
Methods. Analysis of single-institution consecutive case series of patients who received a prophylactic Optease VCF after
multiple trauma between 08/2003 and 12/2004. Data were collected prospectively.
Results. A total of 37 OptEase filters were inserted prophylactically after multiple trauma (median patient age 35 years,
range, 17e73 years, median ISS 41, range, 17e59). All patients had contraindications for pharmacological prophylaxis for
thromboembolic events. 32 filters (86%) were retrieved after 16 days (range, 7e25 days). 12 of 33 filters (36%) demon-
strated trapped clots/thrombosis within the filter structure on pre-retrieval cavography. Two patients received anticoagu-
lation before filter retrieval due to filter thrombosis (6%). Symptomatic PE was observed in 1 patient (3%) 5 days after
VCF retrieval. Minor caudal filter migration was observed in 1 patient (3%). Overall mortality was 3%.
Conclusions. Retrieval of the OptEase filter is safe and feasible. Temporary filter placement avoids possible long-term com-
plications of permanent VCF. It is an efficient form of PE prophylaxis when temporary contraindications to anticoagulation
are present.
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Among hospitalised patients, those recovering from
major trauma have the highest risk of developing ve-
nous thromboembolic events (VTE).1 In some studies
the risk of deep venous thrombosis (DVT) exceeded
50% when no prophylaxis was used.2 Pulmonary
embolism (PE) was the third leading cause of death
in those who survived longer than 24 hours after
trauma.3 VTE often develops shortly after trauma
emphasising the necessity for early and effective pro-
phylaxis.4 With anticoagulation being the standard for
thromboprophylaxis, low-molecular-weight heparin
has proven to be superior to low-dose heparin.5e7 An-
ticoagulation may be contraindicated in the presence
of severe head injuries or major abdominal trauma.
Vena caval filters are an efficient form of PE pro-
phylaxis that are widely used in high-risk trauma
patients with contraindications to anticoagulant
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tended for permanent use only but complications
such as IVC perforation, occlusion and filter migra-
tion are reported in the literature.8,9 Recently, retriev-
able VCFs have been developed. Contraindications to
pharmacological prophylaxis are only temporary for
most trauma patients, so retrievable VCFs represent
an attractive alternative.10e13
The OptEase filter (Cordis Endovascular, J&J,
Roden, The Netherlands) was first approved as a
permanent VCF. The purpose of this study was to
demonstrate safety, efficiency and indications for
retrieval of the optional OptEase filter in the high-
risk trauma patient.
Materials and Methods
The OptEase vena cava filter was introduced at our in-
stitution in August 2003. All trauma patients receiving
this device between August 1, 2003 and December 31,
2004 were registered and entered in a specific data-
base. Only high-risk multiple trauma patients with
prophylactic VCF placement were included in thisrved.
590 C. Meier et al.case series. Patients with therapeutic filter placement
or minor trauma were excluded. Multiple trauma was
defined according to the guidelines of the German
Society for Trauma Surgery as life threatening injury
to several physical regions/organ systems with an
Injury Severity Score (ISS) 16.
All high-risk trauma patients received prophylaxis
with pharmacologicmethods being themost frequently
used. For high-risk patients with contraindications to
anticoagulation, prophylactic vena caval filters were
used. Indications for prophylactic filter placement after
trauma were based upon the guidelines of the Eastern
Association for the Surgery of Trauma (EAST). The def-
inition of high-risk patients included injury patterns re-
sulting in immobilisation for a prolonged period such
as severe head trauma, incomplete spinal cord injury,
complex pelvic fractures with associated long bone
fractures or multiple long bone fractures.6 The VTE
risk of our study population was assessed using the
Risk Assessment Profile for Thromboembolism (RAPT
score) within the first 24 hours after trauma.14,15 This
score considers a number of risk factors. Patients with
a score of 5 or more are three times more likely to
develop VTE than patients with a RAPT score of less
than 5. All patients in our series had a RAPT score 5
ranging from 5 to 22 (median, 15) showing consistency
between the EAST guidelines and the RAPT score in
identification of high-risk patients.
A total of 3852 patients were admitted to the
trauma service during the study, including 268 pa-
tients with multiple trauma (median ISS, 33, range,
17e59). Prophylactic Optease vena cava filters were
placed in 37 patients representing 14% of all major
trauma and 1% of all trauma admissions. No other
filter types or therapeutic filters were inserted for
trauma patients in this period.
Themedian age of patients was 35 years (range, 17e
73 years) with 14 women (38%) and 23 men (62%). ISS
of the study population ranged from 17 to 59 (median
ISS 41). Thoracic and abdominal injuries were among
the most frequent trauma patterns (Table 1). Median
hospital stay was 28 days (range, 11e139 days) includ-
ing 15 days at the ICU (range, 1e53 days). Mechanical
Table 1. Injury pattern
Injury AIS>2
Head 17 (46%)
Face 4 (11%)
Chest 30 (81%)
Abdomen 24 (65%)
Pelvis 19 (51%)
Spine 11 (30%)
Extremity 20 (54%)
Integument 1 (3%)
AIS, Abbreviated Injury Score.Eur J Vasc Endovasc Surg Vol 32, November 2006ventilation was performed in 32 patients (87%) for 1 to
27 days (median, 9 days).
The OptEase filter is based on a permanent IVC fil-
ter design, the Cordis TrapEase filter which can either
be retrieved or remain permanently implanted. It is
made from a single nitinol metal tube with a double-
basket design with six straight struts connecting the
proximal and distal baskets. This self-centring design
provides dual-level filtration. Percutaneous placement
is possible from both jugular and femoral routes using
a 6-F delivery system. The OptEase filter has six fixa-
tion barbs at the cranial end of the device to prevent
cranial migration. A hook at the caudal end of the filter
allows retrieval with an endovascular snare. Percuta-
neous retrieval is only possible from a transfemoral
approach requiring a 10-F guiding catheter is required.
One benefit of using the femoral approach over the
jugular approach during retrieval is the avoidance of
inadvertent passage of the retrieval sheath through
the heart, which would lessen the potential for myo-
cardial injury or arrhythmia. It is the only retrievable
filter that can be recovered from a femoral approach.
All filters were placed and retrieved by an experi-
enced interventional radiologist under fluoroscopic
guidance in the angiography suite. Filters were left
in place for at least 7 days. Retrieval was routinely
performed when there was no longer a contraindica-
tion to prophylactic anticoagulation. Maximal in-
dwelling time before filter retrieval was 28 days. If
filter retrieval was not possible within this period,
filters were left permanently. Before filter retrieval
patients were assessed clinically for DVT of the lower
extremities. Asymptomatic patients were not rou-
tinely evaluated for occult DVT. For patients with sus-
pected DVT duplex ultrasonography was undertaken.
Inferior cavography was performed in order to assess
patency of the IVC and rule out potential filter migra-
tion (Fig. 1). In the presence of trapped clot in the
filter, the size of the clot was assessed in relation to
the inner diameter of the IVC. For thrombus 25%
the filter was retrieved in the same session without
additional measures. For larger clots retrieval was de-
layed and anticoagulation therapy was initiated.
Thrombolysis was never considered due to the risk
of haemorrhagic complications. Retrieval was not
considered in patients with long-standing contraindi-
cations to prophylactic anticoagulation or in the pres-
ence of persisting filter thrombosis >25%.
Results
Median interval between trauma and VCF placement
was 1 day (range, 0e11 days). Patients who were seen
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Fig. 1. VTE prophylaxis: current algorithm in the high-risk trauma patient.initially at another hospital and then referred to our
trauma centre had a longer delay (n¼ 10). For 27 pa-
tients who were directly transferred to our unit after
trauma, the longest interval was 7 days. 36 OptEase
filters were placed percutaneously through the femo-
ral approach (97%). The right jugular vein was ac-
cessed in 1 patient (3%) due to the pattern of injury.
Retrieval was performed using the transfemoral
approach.
A Duplex scan was performed in 12 patients (32%)
with clinical suspicion of DVTof the lower extremities
before filter retrieval, but no DVT was discovered. 32
VCFs were retrieved (86%) after 16 days (range, 7e25
days). Technical success rate of retrieval was 100%.33 patients underwent inferior cavography before
retrieval. 12 filters presented with strands of organ-
ised thrombus on the filter struts (36%). In 8 cases
with a thrombotic mass 25% (24%) the filter was
immediately removed in the same session without
additional treatment. Preretrieval cavography demon-
strated partial filter thrombosis (50e75%) in 4 cases
(12%) which was combined with minor caudal VCF
migration in 1 patient (3%, Fig. 2AeD). Retrieval
was delayed and anticoagulation therapy was initi-
ated for 2 patients 12 days after trauma as they had
no ongoing contraindication to anticoagulation. On
follow-up cavography 22- and 25 days after trauma,
no residual filter thrombosis was seen. UneventfulEur J Vasc Endovasc Surg Vol 32, November 2006
592 C. Meier et al.Fig. 2. A. Fluroscopy after filter placement demonstrates correct filter position (level L3). B. Fluoroscopy 12 days after
insertion shows caudal filter migration (level L4) towards the right common iliac vein ( ). C. Inferior cavography before
potential retrieval shows partial filter thrombosis 12 days after insertion. D. Inferior cavography 25 days after VCF insertion
(following 13 days of therapeutic anticoagulation) shows a patent IVC without any residual filter thrombosis. Uneventful
filter retrieval was performed following cavography.retrieval of both devices was performed in the same
session. Another patient had his filter retrieved and
successfully replaced by a second device in order to
prevent impending IVC occlusion in the same session
13 days after initial placement. The second filter
was necessary due to ongoing contraindication toEur J Vasc Endovasc Surg Vol 32, November 2006anticoagulation after a severe head injury. Uneventful
retrieval of the second VCF was performed 12 days
later. Filter retrieval was cancelled due to partial filter
thrombosis seen on preretrieval cavography and on-
going contraindication to therapeutic anticoagulation
in 1 patient. 3 filters (8%) were left permanently due
593Retrievable Prophylactic Vena Cava Filter in Traumato severe brain injuries and abdominal trauma with
long lasting contraindications to pharmacologic
prophylaxis and 1 patient died due to a severe brain
injury 15 days after trauma before retrieval was con-
sidered. In total, 5 patients (14%) did not have their
VCF’s retrieved.
Symptomatic PE was seen in 1 patient (3%) 5 days
after filter retrieval. This severely injured patient (ISS
50) showed no signs of DVT and no pathology was
seen on preretrieval cavography 17 days after VCF
placement. Following retrieval prophylactic low-
dose heparin was initiated. PE was confirmed 5
days later by contrast-enhanced helical CT scan and
a second VCF was immediately placed as therapeutic
anticoagulation was not possible due to imminent
danger of secondary brain haemorrhage. This second
filter was retrieved 10 days later when therapeutic
anticoagulation could have been started.
We observed no IVC occlusion or injury. No hae-
matoma, AV-fistula or venous thrombosis occurred
at the access site either for insertion or retrieval.
Mortality was 3%. A 48-year old woman died 15
days after trauma due to a severe brain injury. Death
was unrelated to VCF or venous thromboembolic
events. Autopsy showed a correct filter position and
no signs of VTE or filter thrombosis.
Thirty-three patients were seen in outpatient clinic
6- and 12 weeks following trauma. Three patients
were not available for follow-up. Of the 30 patients
with previous filter retrieval, no one presented with
a history or clinical signs of VTE. No further investi-
gations were performed for detection of occult DVT
in asymptomatic patients.
The 3 patients with permanent VCFs were addi-
tionally assessed by an interventional radiologist
regarding their VTE and filter related complications.
Median follow-up was 5 months (range 3e11 months)
after filter placement. Follow-up included a plain
radiograph of the abdomen and duplex ultrasonogra-
phy for detection of DVT and filter-related complica-
tions. No filter showed signs of migration. Late filter
thrombosis was seen in 1 out of 3 patients. This
patient developed symptomatic DVT despite ade-
quate prophylaxis with deltaparin 4 months after
trauma. Follow-up 1 month later revealed asymptom-
atic IVC occlusion with persistent DVT despite thera-
peutic anticoagulation.
No complication from anticoagulation occurred in
our study group. Of the 32 patients who had their fil-
ters retrieved, 6 patients received therapeutic oral an-
ticoagulation for 6 to16 weeks after trauma according
to their injury pattern. In 20 patients with ongoing
contraindication to anticoagulant therapy, deltaparin
in prophylactic dosage was continued for the sameperiod of time. Six patients did not receive any VTE
prophylaxis at all after filter retrieval.
Discussion
Streiff et al. in a literature review of the outcome of
IVC filter use found a late PE rate of 2.6e3.8%, inci-
dence of DVT ranged from 5.9% to 32% and postphle-
bitic syndrome was observed in 14% to 41%. IVC
thrombosis occurred in 3.6 to 11.2%.8 Decousus et al.
demonstrated a reduction in the incidence of PE in
patients with filters compared with patients treated
with anticoagulant therapy by day 12.16 However,
no difference was found between the two groups con-
cerning PE after two years. The incidence of recurrent
DVTwas significantly higher in patients with VCFs at
the 2-year follow-up. They suggested that late throm-
bosis at the filter site may be related to this excess of
recurrent DVT. The recently published eight-year
follow-up results showed a reduced risk of PE and
a significant increase of symptomatic recurrent DVT
for the filter group.17 No difference was found in the
occurrence of post-thrombotic syndrome. However,
symptomatic VTE andmortality showed no significant
difference. This data support the use of retrievable
VCFs to avoid potential long-term complications.
DVTand PE can occur shortly after trauma. Schultz
found an 24% incidence of asymptomatic PE using
contrast-enhanced helical CT scanning for diagnosis
between 3 and 7 days after trauma.18 Owings demon-
strated that 6% of all PE in trauma patients occurred
within 24 hours after injury.19 Following our concept,
filter placement was performed as soon as possible
and all patients were evaluated for filter retrieval.
We achieved a retrieval rate of 87%. We observed 1
symptomatic PE 5 days after filter retrieval suggesting
that retrieval might have been performed too early.
This patient had no signs of DVT, preretrieval cavog-
raphy showed no pathology and adequate pharmaco-
logic prophylaxis was given. Duplex scanning may be
beneficial to detect occult DVT before VCF retrieval.
Some authors have advocated serial colour-flow
Doppler imaging to detect occult DVT.20,21 Ultra-
sound screening asymptomatic patients may be of
lower sensitivity compared to venography22 and it
may be difficult to perform in patients with injuries
to the lower extremities.3
Cavography before potential filter retrieval re-
vealed partial filter thrombosis in 12 out of 33 pa-
tients (36%). The filters may have trapped small
emboli or thrombogenicity of the filter itself may
have contributed to this finding.10,13 Clinical studies
investigating the TrapEase (Cordis Endovascular,Eur J Vasc Endovasc Surg Vol 32, November 2006
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of nearly identical design-reported an IVC occlusion
rate between 1.5% and 2.9%, comparable to other
filter types.23,24 In vitro testing of different VCFs
showed the highest efficiency for filters with two or
more filtration levels, their clot trapping performance
being significantly superior to conical shaped VCFs.25
Leask et al. demonstrated in an experimental in vitro
study that a partially occluded TrapEase filter caused
flow stagnation/recirculation and turbulence down-
stream from the clot that was considered to be
prothrombotic.26
According to the manufacturer’s recommendation
the OptEase filter should be retrieved within 14
days if placed as a temporary device. This time period
seems rather short as vena caval filtration is often nec-
essary for a longer period. In a goat model, the struts
of OptEase filters were overgrown with neointima 46
days after implantation. The authors concluded that
filter incorporation into the vessel wall decreases the
chance of retrieval and potentially increase the risk
of retrieval complications.27 Filter repositioning to
prolong dwell times or VCF replacement involves at
least one additional procedure which increases cost
and perhaps filter-related morbidity. A retrospective
analysis in the manufacturer’s 510(k) approval re-
quest described 29 patients with a mean implantation
time of 16.4 days and a maximum of 48 days. In our
series filters were retrieved up to 25 days. Our techni-
cal success rate was 100% and all filters were removed
percutaneously without any adverse effects suggest-
ing that extended implantation time is feasible for
the OptEase filter. The maximum period of time dur-
ing which this filter can safely be retrieved has not
been determined. Safe retrieval of OptEase filters up
to 48 days after implantation has been reported in
the literature.28 In the largest clinical series so far,
Rosenthal et al. reported their experience with 94
prophylactic OptEase filter placements in multiple
trauma patients under intravascular ultrasound
guidance.29 They observed 2 groin haematomas (2%)
and 1 insertion site DVT (1%). 31 filters (33%) were
retrieved after 5 to 25 days. Three filters (9%) were
not removed due to significant trapped thrombus
(>25%) within the filter. All patients underwent
Duplex scan before retrieval, but no DVT was
identified.
Other retrievable VCFs such as the Gu¨nther Tulip
filter (William Cook, Bjaekerskov, Denmark) come
with similar recommendations regarding implanta-
tion time, but much longer intervals up to 317 days
have been reported in the literature.30 Asch has docu-
mented the efficiency of the recovery filter (Bard, West
Sussex, England), like the OptEase device made fromEur J Vasc Endovasc Surg Vol 32, November 2006nitinol, in 32 patients with a maximum implantation
time of 134 days.31
Selected trauma patients benefit from removable
VCFs as retrieval avoids the potential long-term com-
plications of permanent filters.
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